Patient Rating:

4.8 out of 5

127 Patient Ratings
68 Patient Comments

Kenneth F. Grossmann, M.D., Ph.D.

Patient Rating:

4.8 out of 5

127 Patient Ratings
68 Patient Comments



  • English

Clinical Details

Phone Number Clinical Office Address
(801) 585-0206
Huntsman Cancer Institute
Clinic 2D, Melanoma
2000 Circle of Hope
Salt Lake City, UT 84112



Kenneth Grossmann, MD, PhD

Assistant Professor, Division of Oncology, Department of Medicine

Kenneth Grossmann, MD, PhD, is an assistant professor in the Division of Oncology for the Department of Medicine and a Huntsman Cancer Institute investigator. He is a medical oncologist with the Melanoma and Cutaneous Oncology Program.

Grossmann sees patients with advanced melanoma and also conducts clinical trials. His laboratory research focuses on a demethylase enzyme complex that can cause the hallmarks of many kinds of cancer, including melanoma. Additionally, he focuses on understanding other signaling pathways in melanoma tumors and developing methods to overcome resistance to targeted therapies. Better understanding of melanoma tumor biology may lead to new ways to treat the disease.

Grossmann completed undergraduate studies in biology at Whitman College in Walla Walla, Washington. He earned his PhD and MD degrees from the Department of Molecular and Medical Genetics at Oregon Health & Sciences University (OHSU) in Portland. He completed a combined fellowship in medical oncology at OHSU and the University of Utah, and also participated in a melanoma and cutaneous oncology rotation at MD Anderson Cancer Center.

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Oncology
Board Certification National Board of Medical Examiners
American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)
Cancer Center Programs Experimental Therapeutics

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
My confidence in care provider
Time care provider spent with me
Care provider spoke using clear language
Care provider's effort to include me in decisions
Care provider's concern for questions & worries
Care provider's explanation of condition/problem
Wait time at clinic
Care provider's friendliness and courtesy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

December 20, 2016

Both Dr. Andtbacka and Dr. Grossmann are wonderful. Carolyn is a wonderful NP. Brittany is a nice PA. The providers are wonderful.

December 20, 2016

Dr. Ken Grossman is an incredible doctor that has my upmost trust.

December 11, 2016

Dr Grossmann expressed great confidence in my treating physician, Dr Karl Lewis. As I was seeking a second opinion, his opinion of Dr Lewis was very meaningful. Dr Grossmann's knowledge and expertise is surely one of the reasons the Huntsman Cancer Institute is rated so highly. I wish they were not 450 miles away from me.

November 22, 2016

Dr. Grossmann never makes me feel rushed. He answers all of my questions and concerns. He asks about my family and how I'm doing. I feel he is genuinely interested and doesn't make me feel like just another cancer patient.

September 23, 2016

We talked too long, he was probably late for his next appointment, for which we are very sorry.

August 11, 2016

Dr Grossman always takes the time to answer any questions and explains in language we can understand

June 29, 2016

I love meeting with Dr. Grossmann & Carolyn. Carolyn has genuine concern about my scan results and is just as happy as I am when those results are good. She remembers my family & my situation, even though I am now on a 6-month scan schedule. She is quick to explain things to my daughter & I and never seems rushed to get to the next appointment. We're friends, as well as patient/Doctor!

June 16, 2016

Never saw the Doctor only the PA

June 03, 2016

Dr Grossman and his assistant, Carolyn, were outstanding in their ability to relate and be sensitive to our cancer concerns, as always. Even though I know they see hundreds of needy patients every month. Great people/persons!

May 26, 2016

I do not believe I would be this healthy if not for their staff

April 17, 2016

My family was with me and they will also confirm that I was given the greatest care and attention that any of us had seen. None of us would have any complaints or comments. We felt heard, like we could have as much time as we needed with the different doctors. Never once did I feel rushed, or like I had unanswered questions.

March 27, 2016

Although we encountered some waiting time on this visit, we realize that other patients may have needed extra time and that should our concerns require more time than has been allotted, we, too, will be given all the time that is needed to address our issues.

March 26, 2016

When the staff , including Dr. Grossman, came to discuss my situation I felt I had their complete attention. I did not feel like I was just another patient till they see the next patient. They let me feel like I was part of the team! That means so much to me! A previous health care provider while very competent made me feel like I was a problem to be solved without my input. Thank you!

March 21, 2016

I could not do better than Dr Grossmann. I am so glad that when I checked in, he was the one that I was assigned to.

March 17, 2016

Carolyn Luckett, Dr. Kenneth Grossmann and Andrew Grandemange were all caring and took the time to make everything clear as to my next step.

February 19, 2016

The staff was overbooked for some reason. Just fell behind.

February 10, 2016

I can't say anything bad about my experience that I have had. I feel welcome when I go to my appointments and like the way that the staff remembers me. I feel like I'm not just another number.

January 07, 2016

Comfortable time w doc

November 16, 2015

Doctor and Nurse Practitioner spent most of time talking back and forth between them with no involvement of patient

October 09, 2015


September 13, 2015

very good positive take aways

August 15, 2015

I would not be here if not for your staff

July 31, 2015

never had a provider spent so much time explaining and listening

July 19, 2015

Dr. Grossmann and Carolyn his NP are excellent and caring--makes it worth the long wait to get in

July 13, 2015

Dr Grossman is, in my opinion the most competant and amazing Dr that I have ever had the pleasure of working with. He showed genuine concern for my condition and treatment and was diligent in working to keep the discomfort and side affects to a minimum.

June 25, 2015

beyond my expectations!

May 02, 2015


April 24, 2015


April 12, 2015

My previous comment about kindness applies here.

April 03, 2015

I have referred patients here

March 21, 2015

The staff of Dr.Grossman and the assistance of the office for appointment get a a

March 15, 2015

Dr. Grossman and Carolyn are wonderful. That makes up for the long wait times.

March 15, 2015

It was the most painless stick procedure to draw blood I have ever had. Didn't even leave a bruised spot.

March 13, 2015

we both feel that Dr. Grossmann may have rushed into a chemo only treatment plan and feel better that we held off that and talked with Dr. Hitchcock. Having a full body PET scan will give both doctors a better idea of just how much treatment is needed. Dr. Grossmann is a very competant doctor but we are glad to have Hitchcock in on the treatments also.

March 12, 2015

I received print outs about the last results of my CT scan, but after reading them some of the "new" tumors were not discussed by the Dr or the nurse. I get frustrated sometimes because I feel like not enough attention was given to the scans- I get mixed results sometimes.

February 08, 2015

Dr. Grossmann was very apologetic about his arriving late due to another patient. I told him as long as he takes care of me as well as his last patient that made him late I was OK. I like him very much and feel he has my best interest in mind.

January 20, 2015

My confidence in this care provider is even better than "very good" it is GREAT!!!

December 13, 2014

best team ever!

December 01, 2014

Huntsman really was an amazing experience. Professionalism, Care, Cleanliness, Food. No where else have I experienced such a hospital stay.

November 23, 2014

Dr. Grossman was amazing. I was visiting to get a second opinion about some scans after transferring my care to a different clinic when I moved out of state two years ago. He showed me the new scans, compared them to some old ones, and did a very good job of clearly explaining similarities and differences and walking me through what the implications were. I don't have the words to express how impressed I was.

November 15, 2014

With each visit, I am more impressed and inspired.

November 11, 2014

everyone is the very best, they all go above what is expected

September 13, 2014

Dr. GROSSMAN gives you 110% of his time. He has saved my life and gives me a promising outlook.

June 26, 2014

Theseguys r the best

June 07, 2014

Every one seems to care and no one speaks above our heads, nor do they treat us as if we can't understand. Everything is explained well and we always feel welcome to ask about any thing.

May 14, 2014


April 05, 2014

Dr Grossman is so good in how he talks about the cancer, he brings peace and hope into my soul, the cancer will probably not go away, but this team is very comforting

March 06, 2014

I tell everyone I talk with, to go to Huntsman first, if cancer is a concern.

January 12, 2014


August 12, 2013


June 04, 2013

Dr. Grossmann and his staff are amazing. Thank you to all of you for making my mom's visits something she actually looks forward to.

May 20, 2013

best ever!!

November 26, 2012

These guys are the best!

November 19, 2012

This was a consultation, so no treatment plan was made.

November 06, 2012

I am at the best cancer hospital I can be at and getting care from a team of Doctors that are the best!

November 05, 2012

Dr. Grossmann and his staff are very kind and good to get explanations and next steps. I really like them and think I'm getting the best care for my situation.

October 29, 2012

I can't even begin to describe how much I appreciate Dr. Grossman's attentive care.

September 14, 2012

Dr. Grossmann and his staff are wonderful, caring people. I appreciate all that they do for us.

April 26, 2012

Dr. Kenneth Grossman is a great doctor and I am fortunate to have him on my team, working to solve my health issues. Also, I'd like to mention the great care and effort I feel from my other main two contacts at Huntsman, Karen O'Driscoll and Caroyn Luckett.

April 26, 2012

I highly recommend the Huntsman Center.

April 25, 2012

Can't ask for better care anywhere.

March 28, 2012

I understand the tremendous about of time individual care takes. I have never felt rushed, I was always made to feel my personal worth and health was their primary concern.

March 05, 2012

don't remember

March 01, 2012

Again, I am so glad I started treatment at Huntsman and have been totally pleased with my care.

February 08, 2012

I know without this institute, the research done and the professionalism in every area showen by the doctors and staff, I wouldn't be here today. Circle of hope was the correct address, because the entire staff gives not only hope, but a reason to fight.

February 02, 2012

Dr. Grossman and his staff are A1 and we feel very comfortable with all of them.

January 05, 2012

received excellent news about my prognosis,and all careproviders were encouraging

January 04, 2012

I'm amazed at Dr Grossmann's knowledge. He is an expert with his field andothers. He follows up with any referrals. I trust him.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Oncology
Board Certification National Board of Medical Examiners
American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-0255 Huntsman Cancer Institute
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Dr. Grossmann received his medical and doctorate degrees from the Oregon Health Sciences University (OHSU) in Portland Oregon. He completed his residency training in internal medicine at OHSU. As a resident, Dr. Grossmann was awarded the John S. Miller Teaching Award by the graduating medical students in 2005– an award given to the most gifted educator among all interns. During his subspecialty training in medical oncology, Dr. Grossmann completed clinical and research work at OHSU, the University of Utah, and the MD Anderson Cancer Center in Houston Texas where he focused his training on the clinical care of Stage III and IV melanoma patients. In 2009 Dr. Grossmann joined the University of Utah faculty in the Department of Medical Oncology, and advanced to the rank of Assistant Professor in 2011. He is an investigator in the Huntsman Cancer Institute and a member of the Experimental Therapeutics program. Dr. Grossmann is a physician-scientist whose research focus is on understanding the mechanisms of drug resistance, and radiation resistance of melanoma and other cancers. He has published in peer reviewed journals such as Cell, Mutation Research, Diagnostic Cytopathology, and Journal of Translational Medicine. Dr. Grossmann is recognized regionally, nationally, and internationally as a melanoma expert, and as such has been an invited speaker at the Society of Utah Medical Oncology, and at the Future Perspectives in Melanoma Research Meeting in Naples Italy in 2011. He is an active member of the Southwest Oncology Group where he focuses on the design and execution of clinical trials to define the standard of care in melanoma medical oncology. In addition to his work on melanoma, Dr. Grossmann also sees patients with non-melanomatous tumors such as basal cell carcinoma, squamous cell carcinoma of the skin, and cancers of the head and neck. He serves on the National Comprehensive Cancer Network (NCCN) panel for non-melanomatous skin tumors which defines national standards for the oncologic care of these tumor types.


Education History

Type School Degree
Fellowship University of Utah School of Medicine
Medical Oncology
Fellowship Oregon Health Sciences University
Medical Oncology
Residency Oregon Health Sciences University
Internal Medicine
Internship Oregon Health Sciences University
Internal Medicine
Professional Medical Oregon Health Sciences University
Doctoral Training Oregon Health Sciences University
Molecular and Medical Genetics
Undergraduate Whitman College


Selected Provider Publications

Journal Article

  1. Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor DR, Salama AK, Taylor MH, Ott PA, Horak C, Gagnier P, Jiang J, Wolchok JD, Postow MA (2016). Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.LID - S1470-2045(16)30366-7 [pii]LID - 10.1016/S1470-2045(16)30366-7 [doi]. (Epub ahead of print) Lancet Oncol.
  2. Jimeno A, Posner MR, Wirth LJ, Saba NF, Cohen RB, Popa EC, Argiris A, Grossmann KF, Sukari A, Wilson D, Zhang X, Sun J, Glasser C, Attie KM, Sherman ML, Pandya SS, Weiss J (2016). A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.LID - 10.1002/cncr.30317 [doi]. (Epub ahead of print) Cancer.
  3. Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT (2016). A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.LID - 10.18632/oncotarget.10453 [doi]. (Epub ahead of print) Oncotarget.
  4. Stenehjem DD, Toole M, Merriman J, Parikh K, Daignault S, Scarlett S, Esper P, Skinner K, Udager A, Tantravahi SK, Gill D, Straubhar AM, Agarwal AM, Grossmann KF, Samlowski WE, Redman B, Agarwal N, Alva A (2016). Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2. (Epub ahead of print) Cancer Immunol Immunother.
  5. Pfeffer SR, Grossmann KF, Cassidy PB, Yang CH, Fan M, Kopelovich L, Leachman SA, Pfeffer LM (2015). Detection of Exosomal miRNAs in the Plasma of Melanoma Patients. J Clin Med, 4(12), 2012-27.
  6. Grossmann KF, Suttle AB, Ouellet D, Richards-Peterson LE, Aktan G, Gordon MS, LoRusso PM, Infante JR, Sharma S, Kendra K, Patel M, Pant S, Arkenau HT, Middleton MR, Blackman SC, Botbyl J, Carson SW (2015). Assessment of the Drug Interaction Potential and Single- and Repeat-Dose Pharmacokinetics of the BRAF Inhibitor Dabrafenib. J Clin Pharmacol, 55(4), 392-400.
  7. Weber JS, DAngelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, Hoeller C, Khushalani NI, Miller WH Jr, Lao CD, Linette GP, Thomas L, Lorigan P, Grossmann KF, Hassel JC, Maio M, Sznol M, Ascierto PA, Mohr P, Chmielowski B, Bryce A, Svane IM, Grob JJ, Krackhardt AM, Horak C, Lambert A, Yang AS, Larkin J (2015). Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol, 16(4), 375-84.
  8. Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, Shrieve DC (2015). Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. J Neurosurg, 1-7.
  9. Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC (2014 Mar). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. Journal of the American Academy of Dermatology, 70(3), 435-42.
  10. Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC (2014). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. J Am Acad Dermatol, 70(3), 435-42.
  11. Alwan LM, Grossmann K, Sageser D, Van Atta J, Agarwal N, Gilreath JA (2014). Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma. Target Oncol, 9(1), 63-71.
  12. Anker CJ, Ribas A, Grossmann AH, Chen X, Narra KK, Akerley W, Andtbacka RH, Noyes RD, Shrieve DC, Grossmann KF (2013). Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol, 31(17), e283-7.
  13. Ouellet D, Grossmann KF, Limentani G, Nebot N, Lan K, Knowles L, Gordon MS, Sharma S, Infante JR, Lorusso PM, Pande G, Krachey EC, Blackman SC, Carson SW (2013). Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors. J Pharm Sci, 102(9), 3100-9.
  14. Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z, Ostanin K, Rogers A, Grossmann KF, Tripp SR, Thomas KR, DSouza-Schorey C, Odelberg SJ, Li DY (2013). The small GTPase ARF6 stimulates beta-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal, 6(265), ra14.
  15. Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, Grossman D, Anker C, Florell SR, Bowen A, Duffy KL, Leachman SA, Noyes RD (2013). Sentinel lymph node biopsy for melanoma in pregnant women. Ann Surg Oncol, 20(2), 689-96.
  16. Ascierto PA, Grimaldi AM, Curti B, Faries MB, Ferrone S, Flaherty K, Fox BA, Gajewski TF, Gershenwald JE, Gogas H, Grossmann K, Hauschild A, Hodi FS, Kefford R, Kirkwood JM, Leachmann S, Maio M, Marais R, Palmieri G, Morton DL, Ribas A, Stroncek DF, Stewart R, Wang E, Mozzillo N, Marincola FM (2012). Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". J Transl Med, 10, 83.
  17. Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Evans BA, Jensen RL (2012). Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol, 110(2), 257-64.
  18. Rai K, Sarkar S, Broadbent TJ, Voas M, Grossmann KF, Nadauld LD, Dehghanizadeh S, Hagos FT, Li Y, Toth RK, Chidester S, Bahr TM, Johnson WE, Sklow B, Burt R, Cairns BR, Jones DA (2010). DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell, 142(6), 930-42.
  19. Grossmann KF, Ward AM, Matkovic ME, Folias AE, Moses RE (2001). S. cerevisiae has three pathways for DNA interstrand crosslink repair. Mutat Res, 487(3-4), 73-83.
  20. Grossmann KF, Ward AM, Moses RE (2000). Saccharomyces cerevisiae lacking Snm1, Rev3 or Rad51 have a normal S-phase but arrest permanently in G2 after cisplatin treatment. Mutat Res, 461(1), 1-13.
  21. Grossmann KF, Brown JC, Moses RE (1999). Cisplatin DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. Mutat Res, 434(1), 29-39.


  1. Anker CJ, Grossmann KF, Atkins MB, Suneja G, Tarhini AA, Kirkwood JM (2016). Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG). [Review]. Int J Radiat Oncol Biol Phys, 95(2), 632-46.
  2. Grossmann AH, Grossmann KF, Wallander ML (2012). Molecular testing in malignant melanoma. [Review]. Diagn Cytopathol, 40(6), 503-10.


  1. Grossmann KF (2000). DNA repair and cell cycle checkpoints in response to DNA crosslinking agents in S. cerevisiae. PhD Dissertation. Oregon Health Sciences University Library.
  2. Grossmann KF (1994). Genomic imprinting in Drosophila Melanogaster. Undergraduate Senior Thesis. Walla Walla, WA: Whitman College.


  1. Jimeno A, Posner M, Weiss J, Wirth L, Saba N, Cohen RB, Popa E, Argiris A, Grossmann KF, Sukari A, Korth C, Wilson D, McClure T, Alimzhanov M, Pearsall S, Attie KM, Sherman ML, Pandya SS (June 2014). Phase 2 Study of Dalantercept Monotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Abstract]. Poster Presentation ASCO Annual Meeting (May 30 - June 03, 2014).
  2. Chmielowski B, Hamid O, Minor DR, DAngelo SP, Pennock GK, Grossmann KF, Ascierto PA, Daud A, Dummer R, Hodi FS, Lebb S, Robert C, Sosman JA, Yang A, Lambert A, Weber JS (2013). A phase 3 open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) vs investigator’s choice in advanced melanoma patients progressing post anti-CTLA-4 therapy. Abstract #112577. Poster Presentation ASCO Annual Meeting (May 31 - June 4, 2013) [Abstract].
  3. Grossmann KF, Infante JR, LoRusso PM, Sharma S, Blackman SC, Carson SW, Krachey EC, Nebot N, Ouellet D, Gordon MS (2012). Effects of a high-fat meal on the pharmacokinetics of orally administered GSK2118436 in patients with BRAF mutation-positive tumors. Abstract Number 3766. Poster Presentation AACR Annual Meeting 4/4/2012 Chicago IL [Abstract]. Cancer Research, 72:3766, doi:10.1158/153.
  4. Grossmann KF, Ward JH, Akerley WL, Glantz MJ, De Groot JF, Aiken R, Olson JJ, Matsuoka Y, Yu MK, Jensen RL (2010). A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme.Poster presentation ASCO Annual Meeting 6/5/2010 [Abstract]. J Clin Oncol 28:15s, 2010 (suppl; abstr 2095), 28, 2095.
  5. Grossmann KF, Ward AM, Moses RE (2000). Mutants in two DNA polymerases, REV3 and RAD30 differ in cross-link repair [Abstract]. Am J Hum Genet.
  6. Grossmann KF, Bruun DA, Brown JC, Moses RE (1998). The human SNM1 orthologue does not correct a yeast snm1mutant [Abstract]. Am J Hum Genet, 63(4), 2102.
  7. Grossmann KF, Hejna JA, Moses RE (1996). The Fanconi Anemia Group C Gene Shares a Conserved Domain with MEC1 [Abstract]. Am J Hum Genet, 59(4), 2138.


  1. Terakedis BE, Anker CJ, Bowen GM, Andtbacka RHI, Sause WT, Grossmann KF, BowlesTL, Leachman SA, Noyes RD, Hitchcock YJ, Shrieve DC (Pending). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.


  1. Grossmann KF, Ward AM, Moses RE (2000). Cisplatin DNA damage and the cell cycle in S. cerevisiae. Poster session presented at Fifth Cold Spring Harbor Meeting on The Cell Cycle.
  2. Grossmann KF, Ward AM, Matkovic ME, Moses RE (1999). The effects of DNA crosslinks on cell cycle progression in S. cerevisiae. Poster session presented at Eleventh Annual International Fanconi Anemia Scientific Symposium.
  3. Grossmann KF, Ward AM, Matkovic ME, Moses RE (1999). Cisplatin DNA cross-links: cell cycle arrest and repair in S. cerevisiae. Poster session presented at American Society of Microbiology, DNA Repair and Mutageneisis meeting.
  4. Grossmann KF, Ward AM, Moses RE (1999). DNA Repair and Cell Cycle Checkpoints in Response to Crosslinks in Fanconi Anemia and S. cerevisiae. Poster session presented at American Society of Microbiology, yeast Genetics and Human Disease II.
  5. Grossmann KF, Bruun DA, Brown JC, Moses RE (1998). SNM1, a yeast mutant specifically sensitive to DNA crosslinks, is not corrected by overexpression of the human SNM1 cDNA. Poster session presented at Tenth Annual International Fanconi Anemia Scientific Symposium.
  6. Grossmann KF (1998). Cell Cycle Checkpoints and Crosslink Repair in the Yeast S. cerevisiae. Poster session presented at Oregon Health Sciences University, Student Research Forum.
  7. Grossmann KF (1997). The effects of Cisplatin on Gene Expression and the Cell Cycle Checkpoints of Saccharomyces cerevisiae. Poster session presented at Oregon Health Sciences University Student Research Forum.

Clinical Trials

Video & News